1. Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study. Issue 2 (February 2020) Authors: Lonial, Sagar; Lee, Hans C; Badros, Ashraf; Trudel, Suzanne; Nooka, Ajay K; Chari, Ajai; Abdallah, Al-Ola; Callander, Natalie; Lendvai, Nikoletta; Sborov, Douglas; Suvannasankha, Attaya; Weisel, Katja; Karlin, Lionel; Libby, Edward; Arnulf, Bertrand; Facon, Thierry; Hulin, Cyrille; Kortüm, K Mart... Journal: Lancet oncology Issue: Volume 21:Issue 2(2020) Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial. Issue 10 (October 2020) Authors: Kumar, Shaji K; Jacobus, Susanna J; Cohen, Adam D; Weiss, Matthias; Callander, Natalie; Singh, Avina K; Parker, Terri L; Menter, Alexander; Yang, Xuezhong; Parsons, Benjamin; Kumar, Pankaj; Kapoor, Prashant; Rosenberg, Aaron; Zonder, Jeffrey A; Faber, Edward; Lonial, Sagar; Anderson, Kenneth C; R... Journal: Lancet oncology Issue: Volume 21:Issue 10(2020) Page Start: 1317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study. Issue 10297 (24th July 2021) Authors: Berdeja, Jesus G; Madduri, Deepu; Usmani, Saad Z; Jakubowiak, Andrzej; Agha, Mounzer; Cohen, Adam D; Stewart, A Keith; Hari, Parameswaran; Htut, Myo; Lesokhin, Alexander; Deol, Abhinav; Munshi, Nikhil C; O'Donnell, Elizabeth; Avigan, David; Singh, Indrajeet; Zudaire, Enrique; Yeh, Tzu-Min; Allred... Journal: Lancet Issue: Volume 398:Issue 10297(2021) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group. Issue 2 (February 2022) Authors: Raje, Noopur S; Anaissie, Elias; Kumar, Shaji K; Lonial, Sagar; Martin, Thomas; Gertz, Morie A; Krishnan, Amrita; Hari, Parameswaran; Ludwig, Heinz; O'Donnell, Elizabeth; Yee, Andrew; Kaufman, Jonathan L; Cohen, Adam D; Garderet, Laurent; Wechalekar, Ashutosh F; Terpos, Evangelos; Khatry, Navin; ... Journal: Lancet Issue: Volume 9:Issue 2(2022) Page Start: e143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Issue 10 (October 2015) Authors: Huntington, Scott F; Weiss, Brendan M; Vogl, Dan T; Cohen, Adam D; Garfall, Alfred L; Mangan, Patricia A; Doshi, Jalpa A; Stadtmauer, Edward A Journal: Lancet Issue: Volume 2:Issue 10(2015) Page Start: e408 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b–2, open-label study. Issue 12 (December 2022) Authors: Martin, Thomas; Lin, Yi; Agha, Mounzer; Cohen, Adam D; Htut, Myo; Stewart, A Keith; Hari, Parameswaran; Berdeja, Jesus G; Usmani, Saad Z; Yeh, Tzu-Min; Olyslager, Yunsi; Goldberg, Jenna D; Schecter, Jordan M; Madduri, Deepu; Jackson, Carolyn C; Deraedt, William; Gries, Katharine S; Fastenau, John... Journal: Lancet Issue: Volume 9:Issue 12(2022) Page Start: e897 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial. Issue 12 (December 2018) Authors: Trudel, Suzanne; Lendvai, Nikoletta; Popat, Rakesh; Voorhees, Peter M; Reeves, Brandi; Libby, Edward N; Richardson, Paul G; Anderson, Larry D; Sutherland, Heather J; Yong, Kwee; Hoos, Axel; Gorczyca, Michele M; Lahiri, Soumi; He, Zangdong; Austin, Daren J; Opalinska, Joanna B; Cohen, Adam D Journal: Lancet oncology Issue: Volume 19:Issue 12(2018) Page Start: 1641 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma. Issue 2 (12th July 2020) Authors: Shah, Nina; Aiello, Jack; Avigan, David E; Berdeja, Jesus G; Borrello, Ivan M; Chari, Ajai; Cohen, Adam D; Ganapathi, Karthik; Gray, Lissa; Green, Damian; Krishnan, Amrita; Lin, Yi; Manasanch, Elisabet; Munshi, Nikhil C; Nooka, Ajay K; Rapoport, Aaron P; Smith, Eric L; Vij, Ravi; Dhodapkar, Madhav Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma. Issue 2 (12th July 2020) Authors: Shah, Nina; Aiello, Jack; Avigan, David E; Berdeja, Jesus G; Borrello, Ivan M; Chari, Ajai; Cohen, Adam D; Ganapathi, Karthik; Gray, Lissa; Green, Damian; Krishnan, Amrita; Lin, Yi; Manasanch, Elisabet; Munshi, Nikhil C; Nooka, Ajay K; Rapoport, Aaron P; Smith, Eric L; Vij, Ravi; Dhodapkar, Madhav Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma. Issue 2 (12th July 2020) Authors: Shah, Nina; Aiello, Jack; Avigan, David E; Berdeja, Jesus G; Borrello, Ivan M; Chari, Ajai; Cohen, Adam D; Ganapathi, Karthik; Gray, Lissa; Green, Damian; Krishnan, Amrita; Lin, Yi; Manasanch, Elisabet; Munshi, Nikhil C; Nooka, Ajay K; Rapoport, Aaron P; Smith, Eric L; Vij, Ravi; Dhodapkar, Madhav Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗